Controlled Access for Pharmaceutical & Biotech Companies: Why Security Drift Becomes Harder to Defend in Regulated Environments
In regulated environments, access is never just about convenience. It determines who can influence systems, who can view sensitive information, who can make changes, and how confidently an organization can explain those boundaries later. That is why Controlled Access for Pharmaceutical & Biotech Companies should be treated as part of operational control, not as a … Read more
